FST gene therapy (Entos Pharmaceuticals/Dalhousie University)

N/A

Report date: 2025/06/11 11:02:33

Base Information

Drug NameFST gene therapy (Entos Pharmaceuticals/Dalhousie University)
Drug Alias NamepDNA-FST
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionFollistatin agonists
TargetsFollistatin
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDalhousie University
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A